10X Fund, L.P.

Galectin Therapeutics Inc. · 10% Owner

10X Fund, L.P. is listed in public filings as 10 percent owner. This 10X Fund, L.P. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Galectin Therapeutics Inc. (GALT). Investors use 10X Fund, L.P.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Galectin Therapeutics Inc.GALT$204k30.7k sharesSellDec 16, 2025$6.66--